Behind the scenes: Sources of complementarity in R&D

Journal of Economics and Management Strategy

Volumn 23, Issue 1, 2014, Pages 125-148

  Ceccagnoli, Marco ^a   Higgins, Matthew J ^a,b   Palermo, Vincenzo ^a,c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891891854     PISSN: 10586407     EISSN: 15309134     Source Type: Journal    
DOI: 10.1111/jems.12048     Document Type: Article

References (41)

1. Acemoglu, D. and J. Linn, 2004, "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry, " The Quarterly Journal of Economics, 119, 1049-1090.
2. Arora, A. and M. Ceccagnoli, 2006, "Patent Protection, Complementary Assets, and Firms' Incentives for Technology Licensing, " Management Science, 52, 293-308.
3. Arora, A., M. Ceccagnoli, and W.M. Cohen, 2008, "R&D and the Patent Premium, " International Journal of Industrial Organization, 26, 1153-1179.
4. Arora, A., A. Fosfuri, and A. Gambardella, 2001, Markets for Technology: The Economics of Innovation and Corporate Strategy, Cambridge, MA: MIT Press.
5. Arora, A. and A. Gambardella, 1994, "Evaluating Technological Information and Utilizing It: Scientific Knowledge, Technological Capability, and External Linkages in Biotechnology, " Journal of Economic Behavior and Organization, 24, 91-114.
6. Arora, A. and A. Gambardella, 2010, "Ideas for Rent: An Overview of Markets for Technology, " Industrial and Corporate Change, 19, 775-803.
7. Arora, A., A. Gambardella, L. Magazzini, and F. Pammolli, 2009, "A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development, " Management Science, 55, 1638-1653.
8. Berndt, E.R. and L.R. Christensen, 1973, "The Translog Function and the Substitution of Equipment, Structures, and Labor in U.S. Manufacturing 1929-68, " Journal of Econometrics, 1, 81-113.
9. Bresnahan, T. and A. Gambardella, 1998, "The Division of Inventive Labor and the Extent of the Market, " in E. Helpman, ed. General Purpose Technologies and Economic Growth, Cambridge, MA: MIT.
10. Cassiman, B. and R. Veugelers, 2006, "In Search of Complementarity in Innovation Strategy: Internal R&D and External Knowledge Acquisition, " Management Science, 52, 68-82.
11. Chan, T., J.A. Nickerson, and H. Owan, 2007, "Strategic Management of R&D Pipelines with Cospecialized Investments and Technology Markets, " Management Science, 53, 667-682.
12. Cohen, W.M. and D.A. Levinthal, 1989, "Innovation and Learning: The Two Faces of R&D, " Economic Journal, 99, 569-596.
13. Danzon, P.M., S. Nicholson, and N.S. Pereira, 2005, "Productivity in Pharmaceutical-Biotechnology R&D: The Role of Experience and Alliances, " Journal of Health Economics, 24, 317-339.
14. Danzon, P.M., A. Epstein, and S. Nicholson, 2007, "Mergers and Acquisitions in the Pharmaceutical and Biotech Industries, " Managerial and Decision Economics, 28, 307-328.
15. Forman, C., A. Goldfarb, and S. Greenstein, 2008, "Understanding the Inputs into Innovation: Do Cities Substitute for Internal Firm Resources?, " Journal of Economics & Management Strategy, 17, 295-316.
16. Fosfuri, A., M.S. Giarratana, and A. Luzzi, 2008, "The Penguin Has Entered the Building: The Commercialization of Open Source Software Products, " Organization Science, 19, 292-305.
17. Glaeser, E.L., D.I. Laibson, J.A. Scheinkman, and C.L. Soutter, 2000, "Measuring Trust, " The Quarterly Journal of Economics, 115, 811-846.
18. Grabowski, H., 2002, "Patents, Innovation and Access to New Pharmaceuticals, " Journal of International Economic Law, 5, 849-860.
19. Greene, W.H., 2012, Econometric Analysis, seventh edition, Upper Saddle River, NJ: Prentice Hall.
20. Guedj, I., 2005, "Ownership vs. Contract: How Vertical Integration Affects Investment Decisions in Pharmaceutical R&D, " McCombs Research Paper Series No. FIN-01-06. SSRN. Available at: http://ssrn.com/abstract=677371 (accessed June 6, 2012).
21. Hall, B.H., 1993, "Industrial Research During the 1980s: Did the Rate of Return Fall?, " Brookings Papers on Economic Activity: Microeconomics, 2, 289-343.
22. Hayashi, F., 2000, "Econometrics. 2000, " Princeton University Press. Section, 1, 60-69.
23. Henderson, R. and I. Cockburn, 1996, "Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery, " RAND Journal of Economics, 27, 32-59.
24. Higgins, M.J. and D. Rodriguez, 2006, "The Outsourcing of R&D through Acquisitions in the Pharmaceutical Industry, " Journal of Financial Economics, 80, 351-383.
25. Knowles, S.M. and M. Higgins, 2011, "Vertical Disintegration in the Pharmaceutical Industry and the Role of Ip, " Intellectual Asset Management, 45, 10-15.
26. Laursen, K. and A. Salter, 2006, "Open for Innovation: The Role of Openness in Explaining Innovation Performance among U.K. Manufacturing Firms, " Strategic Management Journal, 27, 131-150.
27. Lowe, J. and P. Taylor, 1998, "R&D and Technology Purchase through Licence Agreements: Complementary Strategies and Complementary Assets, " R&D Management, 28, 263-278.
28. Malerba, F. and L. Orsenigo, 2000, "Knowledge, Innovative Activities and Industrial Evolution, " Industrial and Corporate Change, 9, 289-314.
29. Milgrom, P. and J. Roberts, 1990, "The Economics of Modern Manufacturing: Technology, Strategy, and Organization, " American Economic Review, 80, 511-528.
30. Morgan Stanley Research Europe, 2010, "Pharmaceuticals: Exit Research and Create Value, " Morgan Stanley, New York.
31. Panzar, J.C. and R.D. Willig, 1981, "Economies of Scope, " American Economic Review, 71, 268-272.
32. Pisano, G.P., 1990, "The R&D Boundaries of the Firm: An Empirical Analysis, " Administrative Science Quarterly, 35, 153-176.
33. Pollak, R.A., R.C. Sickles, and T.J. Wales, 1984, "The Ces-Translog: Specification and Estimation of a New Cost Function, " The Review of Economics and Statistics, 66, 602-607.
34. Rothaermel, F.T., M.A. Hitt, and L.A. Jobe, 2006, "Balancing Vertical Integration and Strategic Outsourcing: Effects on Product Portfolio, Product Success, and Firm Performance, " Strategic Management Journal, 27, 1033-1056.
35. Scherer, F., 2007, "Pharmaceutical Innovation, " AEI-Brookings Center Working Paper.
36. Teece, D.J., 1986, "Profiting from Technological Innovation: Implications for Integration, Collaboration, Licensing and Public Policy, " Research Policy, 15, 285-305.
37. Tollman, P., Y. Morieux, J.K. Murphy, and U. Schulze, 2011, "Identifying R&D Outliers, " Nature Reviews Drug Discovery, 10, 653-654.
38. Tsai, K.-H. and J.-C. Wang, 2008, "External Technology Acquisition and Firm Performance: A Longitudinal Study, " Journal of Business Venturing, 23, 91-112.
39. Vega-Jurado, J., A. Gutiérrez-Gracia, and I. Fernández-de-Lucio, 2009, "Does External Knowledge Sourcing Matter for Innovation? Evidence from the Spanish Manufacturing Industry, " Industrial and Corporate Change, 18, 637-670.
40. Vives, X., 2008, "Innovation and Competitive Pressure, " The Journal of Industrial Economics, 56, 419-469.
41. Zollo, M. and S.G. Winter, 2002, "Deliberate Learning and the Evolution of Dynamic Capabilities, " Organization Science, 13, 339-351.